|
Market Closed -
Nasdaq
02:30:00 18/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 7.130 USD | -3.26% |
|
-0.42% | -60.74% |
| 06/11 | BofA Securities Adjusts Avalo Therapeutics Price target to $24 From $29 | MT |
| 05/11 | Wedbush Adjusts Price Target on Avalo Therapeutics to $20 From $22, Keeps Outperform Rating | MT |
Stock exchange
Quotes 5-day view: Avalo Therapeutics, Inc.
Delayed Quote Nasdaq| 11/11/2026 | 12/11/2026 | 13/11/2026 | 16/11/2026 | 17/11/2026 | |
|---|---|---|---|---|---|
| Last | $8.510 | $7.700 | $7.760 | $7.370 | $7.130 |
| Volume | 18,39,395 | 29,60,580 | 9,74,224 | 11,16,528 | 31,33,750 |
| Change | +18.85% | -9.52% | +0.78% | -5.03% | -3.26% |
| Opening | $7.240 | $8.290 | $7.730 | $7.760 | $7.570 |
| High | $8.550 | $8.390 | $7.940 | $7.830 | $7.570 |
| Low | $7.170 | $7.410 | $7.445 | $7.260 | $6.880 |
Performance
| 1 day | -3.26% | ||
| 1 week | -0.42% | ||
| Current month | -0.56% | ||
| 1 month | -36.73% | ||
| 3 months | -64.26% | ||
| 6 months | -59.81% | ||
| Current year | -60.74% | ||
| 1 year | -57.75% | ||
| 3 years | -66.99% | ||
| 5 years | -99.89% | ||
| 10 years | -99.95% |
Volumes
marketsDaily volume
31,33,757
Estimated daily volume
31,33,757
Avg. Volume 20 sessions
20,69,035
Daily volume ratio
1.51
Avg. Volume 20 sessions USD
1,47,52,219.55
Record volume 1
3,19,10,412
Record volume 2
2,61,89,975
Record volume 3
2,24,60,588
Capital turnover ratio
0.04
Float rotation
0.04
Basic data
Market Cap (USD)
42,61,56,121
Net sales (USD)
59,000
Number of employees
33
Sales / Employee (USD)
1,788
Free-Float
97.1%
Free-Float capitalization (USD)
41,38,18,874
Average Daily Capital Traded
3.46%
Indicators
Moving average 5 days
7.7
Moving average 20 days
7.972
Moving average 50 days
12.33
Moving average 100 days
15.6
Price spread / (MMA5)
+7.99%
Price spread / (MMA20)
+11.81%
Price spread / (MMA50)
+72.88%
Price spread / (MMA100)
+118.74%
STIM
RSI 9 days
44.57
RSI 14 days
38.26
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.26% | -0.42% | -57.75% | -66.99% | 43Cr | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 6.56TCr | ||
| -2.64% | -1.13% | +7.82% | +88.90% | 6.04TCr | ||
| -1.07% | +0.30% | +22.91% | +86.76% | 5.58TCr | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 4.7TCr | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 4.36TCr | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 3.67TCr | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 3.61TCr | ||
| -0.77% | -2.21% | +77.27% | +57.96% | 3.29TCr | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 2.7TCr | ||
| Average | -1.28% | -1.92% | +24.98% | +148.34% | 4TCr | |
| Weighted average by Cap. | -1.00% | -2.20% | +33.85% | +147.20% |
Historical Quotes: Avalo Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
1c3.Qrf4rQpyITSrtxpj5CKdj0RbHS1szlOv8lMVxykLHLQ.dNStnlhBZnzg22kXsXvvxyoreGUDgTLIuhJ682JBJMEJ4avcRj1ABZPFTw
| Date | Price | Volume | Total |
|---|---|---|---|
| 02:30:00 am | 7.130 | 2,08,607 | 27,84,456 |
| 02:29:59 am | 7.140 | 100 | 25,75,849 |
| 02:29:59 am | 7.150 | 100 | 25,75,749 |
| 02:29:59 am | 7.140 | 200 | 25,75,649 |
| 02:29:59 am | 7.140 | 300 | 25,75,449 |
| 02:29:59 am | 7.140 | 700 | 25,75,149 |
| 02:29:59 am | 7.130 | 700 | 25,74,449 |
| 02:29:59 am | 7.130 | 100 | 25,73,749 |
| 02:29:59 am | 7.130 | 326 | 25,73,649 |
| 02:29:59 am | 7.130 | 100 | 25,73,323 |
Price Extremes
| 1 week | 6.88 | 8.39 | |
| 1 month | 6.53 | 13.18 | |
| Current year | 6.53 | 24.27 | |
| 1 year | 6.53 | 24.27 | |
| 3 years | 3.39 | 34.46 | |
| 5 years | 3.39 | 6,566.35 | |
| 10 years | 3.39 | 22,031.54 |
Monthly variations
Annual variations
| 2026 | -60.74% | ||
| 2025 | +144.41% | ||
| 2024 | -18.35% | ||
| 2023 | -99.25% | ||
| 2022 | -75.29% | ||
| 2021 | -35.61% | ||
| 2020 | -51.02% | ||
| 2019 | +66.87% | ||
| 2018 | +0.94% | ||
| 2017 | +263.47% | ||
| 2016 | -73.72% | ||
| 2015 | -16.25% |
- Stock Market
- Stocks
- AVTX Stock
- Quotes Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















